Stereotactic Body Radiation Therapy Could Be Used For Non-Invasive Cardiac Ablation, Study Shows
A five-patient trial shows that cardiac ablation with noninvasive stereotactic cardiac radiotherapy can reduce the burden of ventricular tachycardia. The technique could be a major improvement over catheter ablation, because its non-invasive and would allow for access to areas of the ventricular tachycardia that are inaccessible to catheter ablation. But more trials are needed to refine the technique and improve safety.
You may also be interested in...
Digital Surgery, a London-based developer of surgical artificial intelligence, analytics, digital education and training solutions, will join Medtronic’s surgical robotics business within its minimally invasive therapies group.
In this edition of Device Week, Medtech Insight's managing editor Marion Webb talks with deputy editor Reed Miller about his recent story on Abiomed's plan to counter unfavorable studies of its Impella heart pump.
[Editor's note: This article was updated on 14 February 2020 to clarify that Abiomed has invested more than $100m over the past five years in clinical research on the Impella heart pump platform. Abiomed has not committed to spend another $100m on new physician education and communication programs.]